Given the emerging central role of altered NO signaling in the pathophysiology of priapism associated with SCD, we hypothesized that restored normal NO/cGMP/PKG/PDE5-mediated penile vascular homeostasis in the penis via sustained pharmacotherapeutic inhibitory targeting of PDE5 would attenuate this disorder. The gene discussed is PDE5A; the disease is Priapism.